Table 1. Identification of study populations.
| IDa | Form of leprosy | Gender | Age (ys.) | BIb | LSTc | DGd | MDTe (number of doses) |
|---|---|---|---|---|---|---|---|
| HR001 | T1R | F | 69 | 1.75 | NEG | 1 | 10° |
| HR002 | T1R | F | 25 | 2.5 | NEG | 1 | 8° |
| HR003 | T1R | M | 28 | 1.75 | NEG | 2 | 8° |
| HR004 | T1R | M | 22 | 2.5 | POS | 0 | 9° |
| HR005 | T1R | F | 29 | 1.5 | NEG | 1 | NTf |
| HR006 | T1R | M | 54 | 3.75 | NEG | 3 | NT |
| HR007 | T1R | F | 68 | 2.5 | POS | 2 | NT |
| HR008 | T1R | M | 59 | 2.5 | NEG | 2 | 7° |
| HR009 | T1R | F | 42 | 1.5 | NEG | 1 | NT |
| HR010 | T1R | F | 28 | 2.25 | NEG | 0 | 7° |
| HR011 | T1R | F | 56 | 3.5 | NEG | 3 | NT |
| HR012 | T1R | M | 15 | 1.25 | POS | 1 | 9° |
| BS001 | BL | M | 29 | 3.75 | NEG | 2 | NT |
| BS002 | BL | M | 61 | 4.0 | NEG | 2 | NT |
| BS003 | BL | F | 63 | 3.75 | NEG | 1 | NT |
| BS004 | BL | F | 56 | 2.75 | NEG | 1 | NT |
| BS005 | BL | M | 31 | 2.5 | NEG | 0 | NT |
| BS006 | BL | M | 33 | 3.0 | NEG | 0 | NT |
| BS007 | BL | F | 42 | 2.55 | NEG | 1 | NT |
| BS008 | BL | F | 53 | 3.75 | NEG | 0 | NT |
| BS009 | BL | M | 57 | 4.0 | NEG | 1 | NT |
| BS010 | BL | F | 18 | 2.75 | NEG | 0 | NT |
| SD001 | HV | F | 25 | - | - | - | - |
| SD002 | HV | F | 52 | - | - | - | - |
| SD003 | HV | F | 29 | - | - | - | - |
| SD004 | HV | F | 39 | - | - | - | - |
| SD005 | HV | F | 42 | - | - | - | - |
| SD006 | HV | M | 20 | - | - | - | - |
| SD007 | HV | M | 32 | - | - | - | - |
| SD008 | HV | M | 39 | - | - | - | - |
| SD009 | HV | M | 59 | - | - | - | - |
| SD010 | HV | M | 46 | - | - | - | - |
aID: randomized code for each patient or heathy subject in order to safeguard their identity.
bBI: bacteriological index.
cLST: lepromin skin test [NEG = negative (5.0 mm) and POS = positive (≥5.0 mm)].
dDG: disability grade.
eMDT: multidrug therapy currently recognized by WHO (12 doses).
fNT: not treated.